Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders by Anaïs Nombel, PharmD, Magali Perret, MSc, Sophie Trouillet-Assant, PhD, Marine Villard, PhD, Christine Lombard, PharmD, Lorna Garnier, PharmD, Anne-Perrine Foray, MD, PhD, Sarah Benezech, MD, Remi Pescarmona, PharmD, Samira Khaldi-Plassart, PhD, Thierry Walzer, PhD, Alexandre Belot, MD, PhD, Sébastien Viel, PharmD, PhD

Get full text